Pay in 4 interest-free payments of $43.75 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
43 / An α-D-N-acetylgalactosamine (GalNAcα) ligand equipped with a terminal carboxylic acid through a hydrophilic PEG4 spacer
aa length 11) with STf antigen (Neu5Acα2-3Galβ1-3GalNAcα) at Thr41 and Thr51
enzymatic cleavage of the aglycone-proximal α-glucosidic bond releases 4-nitrophenol
66 / MUC1 (UniProt ID P15941) synthetic glycopeptide fragment (Gly137-Ala141
49 / / Isavuconazole-d4 / BAL 4815-d4
PE132010: β-GalNAc-PEG3-Acid Pack Size:25 mg 43 / An α-D-N-acetylgalactosamine (GalNAcα)C15H27NO10 381. 38 A D N acetylgalactosamine (GalNAc) ligand equipped with a terminal carboxylic acid through a hydrophilic PEG3 spacer. The carboxylic acid can be activated to NHS, sulfo NHS, or pentafluorophenyl esters and reacted with amine functionalized platforms or lysine residues on proteins and peptides to form amide bonds. This compound enables the construction of hepatocyte targeted therapeutics and research tools that exploit the
US$ 60.00
US$ 100.00
US$ 60.00
US$ 100.00
US$ 100.00
